Sinomarin Plus Algae Allergy Relief improves AR control, extending symptom free days and reducing medication used in children with AR
% of Symptom-free days

  • 52% more symptom-free days in the active vs control group
  • 35% less medication received in active group

Adapted from Mitsias et al., 2020; p-values <0.05 are considered significant.
Values shown as medians with 25-75 percentiles.
TSMS: Total Symptom and medication Score; Based on Wilcoxon-sum test
Click for
Study Details

Study Details

Open-label, controlled, non-randomized real-life study including 89 children and adolescents with allergic rhinitis (AR) assessing the addition of Sinomarin Plus Algae Allergy Relief in controlling AR. The Control Group received only medication. The active group also received Sinomarin Plus Algae Allergy Relief adjunct to their medication.

Symptoms were primarily assessed by the control of allergic rhinitis and asthma test (CARAT) questionnaires and were also tracked along with daily medication through a MASK/Allergy Diary application. They were then combined in a novel total symptom/medication score (TSMS)

Product tested: Sinomarin Plus Algae Allergy Relief

 
Total # of participants: 89
 
Mitsias D.I. et. al., Effect of nasal irrigation on allergic rhinitis control in children; complementarity between CARAT and MASK outcomes. Clin Transl Allergy 10, 9 (2020)